This topic contains a solution. Click here to go to the answer

Author Question: A client newly diagnosed with open-angle glaucoma has been prescribed timolol (Timoptic). Prior to ... (Read 53 times)

big1devin

  • Hero Member
  • *****
  • Posts: 583
A client newly diagnosed with open-angle glaucoma has been prescribed timolol (Timoptic). Prior to administering this medication, which condition in the client's history should the nurse immediately inform the prescriber about?
 
  1. Primary hypertension
  2. Deep-vein thrombosis
  3. Supraventricular tachycardia
  4. Asthma

Question 2

A client, concerned about developing glaucoma because a parent has the disorder, asks the nurse about the different types. The nurse responds that both open-angle and closed-angle glaucoma result in:
 
  1. acute eye pain.
  2. floaters in the vitreous humor.
  3. a bulging iris.
  4. an increased volume of aqueous humor.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Eunice618

  • Sr. Member
  • ****
  • Posts: 350
Answer to Question 1

Correct Answer: 4
Rationale 1: Beta blockers are used to treat hypertension and would not be contraindicated for this reason.
Rationale 2: A deep-vein thrombosis would not be a concern when administering timolol.
Rationale 3: Beta blockers can be used to reduce the heart rate. This history would not be a concern when administering timolol.
Rationale 4: Nonselective beta blockers can cause bronchospasm. Clients with asthma are at risk for this adverse effect.
Global Rationale: Nonselective beta blockers can cause bronchospasm. Clients with asthma are at risk for this adverse effect. Beta blockers are used to treat hypertension and would not be contraindicated for this reason. A deep-vein thrombosis would not be a concern when administering timolol. Beta blockers can be used to reduce the heart rate. This history would not be a concern when administering timolol.

Answer to Question 2

Correct Answer: 4
Rationale 1: Acute eye pain is seen with closed-angle glaucoma.
Rationale 2: Floaters are not a major symptom of either type of glaucoma.
Rationale 3: A bulging iris is a manifestation of acute obstruction that is more likely seen with closed-angle glaucoma.
Rationale 4: Both open-angle and closed-angle glaucoma are the result of an accumulation of aqueous humor in the anterior cavity.
Global Rationale: Both open-angle and closed-angle glaucoma are the result of an accumulation of aqueous humor in the anterior cavity. Acute eye pain is seen with closed-angle glaucoma. Floaters are not a major symptom of either type of glaucoma. A bulging iris is a manifestation of acute obstruction that is more likely seen with closed-angle glaucoma.




big1devin

  • Member
  • Posts: 583
Reply 2 on: Jul 23, 2018
Wow, this really help


Hdosisshsbshs

  • Member
  • Posts: 315
Reply 3 on: Yesterday
Gracias!

 

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

A seasonal flu vaccine is the best way to reduce the chances you will get seasonal influenza and spread it to others.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library